Clinical Trial Update: Role of Immune Responses After Acute Myocardial Infarction [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update exploring the role of immune responses after acute myocardial infarction, with a focus on myocardial fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Fibrosis
• Myocardial Infarction

Snippet

Sponsor: Federal University of São Paulo | Conditions: Myocardial Fibrosis | Phase 4 | Status: UNKNOWN